AzTrials
AzTrials

Re-operativeNCT07424768

Re-operative Hypospadias Repair Using Tubularized Incised Plate Urethroplasty

An observational study of Re-operative and Hypospadias, run by Tanta University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the outcomes, feasibility, and complication profile of re-operative hypospadias repair using tubularized incised plate urethroplasty as a single-stage procedure in a single-center experience. Read more about this study

Who is it for?
Ages 1 year to 16 years
What is being tested?
Tubularized Incised Plate Urethroplasty
Type of treatment
Surgery or procedure
How many people
15 participants
Where
1 siteEgypt
Study dates
1 Jan 2021to 1 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: We will conduct a retrospective review of 15 pediatric cases who presented or referred with complications requiring reoperation after primary hypospadias repair, including urethrocutaneous fistula, meatal stenosis, or poor urinary stream. This study will be conducted at Tanta university hospitals from January 2021 to december 2025. The data will be collected from 1st January 2026 to 1st February 2026.

Who may be able to join

  • Both sexes.
  • Children with recurrent or residual hypospadias in whom the urethral plate is deemed suitable for reuse, defined as a plate width of at least 8-9 mm with acceptable vascularity and without severe fibrosis.

Who cannot join

  • Patients with severely scared or fibrotic urethral plates are not suitable for tubularization.
  • Absent or destroyed urethral plates following previous failed hypospadias repairs.
  • Patients require staged urethral reconstruction rather than a single-stage procedure.
  • Presence of poor urethral plate vascularity or ischemic tissue.
  • Extensive penile scarring or fibrosis resulting from multiple previous surgical attempts.
  • Severe penile curvature requiring excision of the urethral plate.
  • Inability to achieve adequate, well-vascularized tissue coverage over the neourethra.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Tanta University

    Tanta, El-Gharbia, 31527

Other trials in Egypt

About this study

The aim of this study is to evaluate the outcomes, feasibility, and complication profile of re-operative hypospadias repair using tubularized incised plate urethroplasty as a single-stage procedure in a single-center experience.

Read the detailed description

Hypospadias repair remains one of the most common reconstructive procedures in pediatric urology; however, re-operative hypospadias represents a challenging subset due to distorted anatomy, urethral plate scarring, deficient local tissues, and higher complication rates compared with primary repairs.

The tubularized incised plate (TIP) urethroplasty, originally described by Snodgrass, revolutionized primary hypospadias repair and has since been adapted for selected reoperative cases. Contemporary evidence suggests that despite prior surgery and scary, a well-vascularized urethral plate of adequate width can still be successfully tubularized following a midline relaxing incision, offering acceptable functional and cosmetic outcomes.

Being tested
Tubularized Incised Plate Urethroplasty
Medical subject headings
Hypospadias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tubularized Incised Plate UrethroplastyProcedure or surgery

    All procedures were performed under general anesthesia using the tubularized incised plate technique. After completing penile degloving and exposure of the urethral plate, a midline longitudinal incision was made along the entire length of the plate to allow tension-free tubularization. The urethral plate was then tubularized over an appropriate-sized urethral catheter using fine absorbable sutures. A well-vascularized dartos flap was harvested and interposed as a protective layer over the neourethra, followed by meticulous skin closure.

Study groups in NCT07424768
Study groupRoleWhat they receive
Study groupChildren with recurrent or residual hypospadias in whom the urethral plate is deemed suitable for reuse.
Receives: Procedure: Tubularized Incised Plate Urethroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success rate

    The success rate of tubularized incised plate urethroplasty reoperation after treatment was recorded.

    Measured: 6 months after the procedure

Secondary outcomes (3)
  1. Incidence of complications

    Incidence of postoperative complications such as fistula, meatal stenosis, glans dehiscence, and urethral stricture were recorded.

    Measured: 6 months after the procedure

  2. Incidence of postoperative urethrocutaneous fistula

    Incidence of postoperative urethrocutaneous fistula was recorded.

    Measured: 6 months after the procedure

  3. Incidence of meatal stenosis

    Incidence of meatal stenosis was recorded.

    Measured: 6 months after the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2026
  2. Study start1 Jan 2021
  3. Primary completion1 Dec 2025
  4. Study completion1 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07424768
Sponsor's protocol ID
36264PR1310136/1/26
Status last verified
Feb 2026
First submitted
14 Feb 2026
Last updated
20 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Questions about this trial

What is this clinical trial studying?

An observational study of Re-operative and Hypospadias, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success rate (time frame: 6 months after the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in